A randomised, phase II, trial comparing the efficacy of single fraction of multi-fraction SABR (Stereotactic Ablative Body Radiotherapy) with Atezolizumab in patients with advanced triple negative breast cancer (AZTEC)

  • White, Michelle (Primary Chief Investigator (PCI))

Project: Other

Project Details

Project Description

NMA HREC Ref number: HREC/17/PMCC/109 (ERM Project ID: 36169
NMA SSA Ref number: SSA/36136/MonH-2018-153652
Monash Health Ref: RES-18-0000-660X
SEO Code: 920102 Cancer and Related Disorders
StatusFinished
Effective start/end date8/11/18 → 7/11/23